2Kuo CC, Gown AM, Benditt EP, et al. Detection of chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochem ical stain. Arterioscle Thromb, 1993,13 : 1501- 1504.
3Becker A,Site ofintimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation, 1994,89:36-44.
4Grufinkel E, Bozovich G, Doroca A,et al. Correlation of chlamydia pneumoniae infection with coronary heart disease. Lancet, 1997,350(9075) : 404-407.
5Shor A,Kuo CC. Patton DL. Detection of chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Aft Med J,1992,82: 158-161.
7Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis.Circulation,2002,105:1135-1143.
8Kvantaliani TG,Pargalava N,Tsiklauri PA,et al.[Chronic bacterial-and-viral vasculitis as a possible risk factor of disordered stability of the coronary atherosclerosis course].Angiol Sosud Khir,2006,12:35-39.
9Yavuz MT,Yavuz O,Yazici M,et al.Interaction between Chlamydia pneumoniae seropositivity,inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.Scand J Clin Lab Invest,2006,66:523-534.
10Sack M.Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease.Pharmacology and Therapeutics,2002,94:123-135.
